CD38 and histiocytic sarcoma: Our data (1) highlight previously unappreciated changes in circulating immune cell subsets in HS; (2) identify CD38 as a marker of inflammation induced in select circulating and cutaneous cell types; and (3) show a preferential accumulation of I.monos in the blood and C.monos in the skin of patients with HS.